Research Paper Advance Articles
Insulin sensitivity in long-lived growth hormone-releasing hormone knockout mice
- 1 Department of Biology, University of Alabama at Birmingham, Birmingham, AL 35254, USA
- 2 Department of Obstetrics and Gynecology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA
Received: April 3, 2020 Accepted: June 5, 2020 Published: July 8, 2020https://doi.org/10.18632/aging.103588
How to Cite
Copyright © 2020 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Our previous studies showed that loss-of-function mutation of growth hormone releasing hormone (GHRH) results in increased longevity and enhanced insulin sensitivity in mice. However, the details of improved insulin action and tissue-specific insulin signaling are largely unknown in this healthy-aging mouse model. We conducted hyperinsulinemic-euglycemic clamp to investigate mechanisms underlying enhanced insulin sensitivity in growth hormone (GH) deficient mice. Further, we assessed in vivo tissue-specific insulin activity via activation of PI3K-AKT and MAPK-ERK1/2 cascades using western blot. Clamp results showed that the glucose infusion rate required for maintaining euglycemia was much higher in GHRH-/- mice compared to WT controls. Insulin-mediated glucose production was largely suppressed, whereas glucose uptake in skeletal muscle and brown adipose tissue were significant enhanced in GHRH-/- mice compared to WT controls. Enhanced capacity of insulin-induced activation of the PI3K-AKT and MAPK-ERK1/2 signaling were observed in a tissue-specific manner in GHRH-/- mice. Enhanced systemic insulin sensitivity in long-lived GHRH-/- mice is associated with differential activation of insulin signaling cascades among various organs. Improved action of insulin in the insulin sensitive tissues is likely to mediate the prolonged longevity and healthy-aging effects of GH deficiency in mice.
GH: growth hormone; GHRH: growth hormone-releasing hormone; WAT: white adipose tissue; vWAT: visceral white adipose tissue; sWAT: subcutaneous white adipose tissue; BAT: brown adipose tissue; FFA: free fatty acid; GIR: glucose infusion rate; GSK3: glycogen synthesis kinase; IRS: insulin receptor substrate; GHRKO: GH receptor/binding protein-deficient; i.p. injection: intraperitoneal injection; HOMA-IR: homeostasis model for assessment of insulin resistance; GTT: glucose tolerance tests; ITT: insulin tolerance test; B.W.: body weight; DXA: dual-energy X-ray absorptiometry; IGF-1: Insulin growth factor-1.